Redefining Medicine

Today's interview on Redefining Medicine features internationally-known physician, speaker and bestselling author Richard Horowitz, MD. Dr. Horowitz discusses what initially motivated him to focus his practice on the treatment of Lyme disease, in addition to his personal connection to the disease. As a member of the Federal Tick-Borne Disease Working Group, Dr. Horowitz has treated thousands of patients with both clinical and integrative approaches, through a developed framework to combat resistant chronic disease. Dr. Horowitz further outlines the importance of treating the microbiome, and understanding the multifactorial causes of autoimmune & chronic diseases, while sharing his personal connection to Daryl Hall of famed music group Hall & Oates.

Today's episode on Redefining Medicine spotlights Todd LePine, MD: a Board-Certified specialist in Integrative Functional Medicine. After "hitting a wall" in treating patients with mainstream allopathic medicine, Dr. LePine discovered the benefits and efficacy of Integrative Medicine in handling chronic conditions, working for 15 years as a physician at Canyon Ranch. Dr. LePine currently practices medicine at The UltraWellness Center—focusing on helping his patients achieve optimal health and vitality by restoring the natural balance to both the mind and body. As a lecturer, researcher, and teacher, Dr. LePine also serves as the current Clinical Medical Director for Metametrix Laboratories, where he teaches physicians the clinical applications of advanced biochemical laboratory testing. Dr. LePine's multidimensional approach to assessing the underlying root causes of disease have helped thousands of patients regain health and vitality through cutting-edge, clinically-proven approaches.

Today's interview on Redefining Medicine features Maria Angelo-Khattar, MD, PhD, a world-renowned lecturer and Fellowship Course Director for the Aesthetic Anti-Aging Fellowship in Dubai. As Dr. Khattar discusses her personal journey and professional career trajectory, she outlines the motivations behind the importance of Anti-Aging and Aesthetic Medicine. While Dr. Khattar's hands-on modules and workshops attract international practitioners from Asia, the Middle East, and Europe, she considers both the similarities and differences of treatments, protocols, and modalities—and how they vary across the globe. Dr. Khattar further explores the ways in which social media impacts and motivates women to seek aesthetic treatments, from the perspective of an actively practicing expert clinician.

Today's interview on Redefining Medicine spotlights CEO and Founder of BodyLogicMD Patrick Savage, as he outlines his experience in the rapidly expanding market of bioidentical hormone replacement therapy. Savage discusses his own personal journey towards wellness, transitioning from an unhealthy lifestyle of burnout to optimal health and happiness. When Savage saw an opportunity to market physician expertise to patients who also wanted to live healthier, better, and longer lives, he established BodyLogicMD. Now operating in 50 locations, across 32 states, with 70 practitioners and 17,000 active patients, BodyLogicMD has evolved into the nation's largest network of highly trained practitioners specializing in hormone replacement therapy.

Today's episode on Redefining Medicine spotlights Robin Farmanfarmaian: entrepreneur, professional speaker, and author of Amazon bestseller "The Patient as CEO: How Technology Empowers the Healthcare Consumer." Originally misdiagnosed with autoimmune disease, by the age of 26 Farmanfarmaian had undergone 43 hospitalizations, 6 major surgeries, and had 3 organs removed. Through taking control of her own health and correctly self-diagnosing, Farmanfarmaian now seeks to empower other patients by sharing her journey, advice, and lessons learned—while delivering information surrounding the various available digital technologies. By investing in cutting-edge companies poised to impact 100 million people or more, Farmanfarmaian works on the most current medical technologies in an effort to better help patients.

Today's episode on Redefining Medicine features Alex Zhavoronkov, PhD. As CEO of Insilico Medicine, Zhavoronkov is a pioneer in artificial intelligence, deep learning techniques, and blockchain technologies for drug discovery and biomarker development. With a long-held belief that the issue of aging needs to be further researched and addressed, Zhavoronkov seeks to discover how precision medicine can further advance treatment protocols for patients. Through research focuses on genomics, epigenetics, and personalized screening techniques, Zhavoronkov works on advancing Regenerative and Anti-Aging Medicine with the most cutting-edge technologies and clinical research.

Today's episode on Redefining Medicine features David Rhew, MD: Chief Medical Officer and Head of Healthcare and Fitness for Samsung Electronics of America. With a background in a variety of leadership and clinical research roles, including Zynx Health Incorporated, the VA Greater Los Angeles Healthcare System, and UCLA, Dr. Rhew focuses on the applications of technology to improve and expand the landscape of healthcare. Through his work to measurably improve the quality, safety, and efficacy of patient care, Dr. Rhew continuously seeks to actively engage patients and consumers in their health. 

Today's interview on Redefining Medicine features Michael Weiner, DO, MSM, MSIST: Chief Medical Information Officer at IBM Healthcare. With a research focus on key issues in today’s evolving healthcare ecosystem, including an aging population, increased technology and data, and new models of care, Dr. Weiner has a demonstrated history of helping to transform healthcare organizations. With extensive experience and skills in team-building and organizational leadership, Dr. Weiner continuously supports the development of innovative healthcare products and services--while addressing critical challenges in the landscape of medicine.

Today's podcast on Redefining Medicine spotlights Peter Diamandis, MD. Named one of the "World's 50 Greatest Leaders" by Fortune Magazine, Diamandis continuously pushes the boundaries of what was once considered possible in the field of healthcare: a thought leader committed to the burgeoning convergence of medicine and technology. Diamandis serves as the Founder & Executive Chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. Diamandis is also the Co-Founder & Executive Chairman of Singularity University, a graduate-level Silicon Valley institution that counsels the world's leaders on exponentially growing technologies. A graduate of MIT and Harvard Medical School, Diamandis is equal parts entrepreneur, visionary, and change-maker of the future.

Today's interview on Redefining Medicine features Pablos Holman: self-described ‘futurist, inventor, and notorious hacker.' Holman has consulted worldwide on invention and design projects that assimilate the newest technological advances and developments. With a current position at the Intellectual Ventures Laboratory, Holman works on a variety of futuristic, innovative projects that spark progress. Some of his initiatives include a fission reactor powered by nuclear waste, a machine to suppress hurricanes, strategies to reverse global warming, and a device designed to shoot mosquitos with lasers in order to eradicate malaria. Holman's work represents an entirely new frontier of medicine, continuously challenging what was once considered possible in healthcare research.